Order results by:
| Issue | Title | |
| Vol 11, No 1 (2015) | VASCULAR COMORBIDITY: GENERAL APPROACHES TO PREVENTION AND TREATMENT | Abstract PDF (Eng) similar documents |
| R. G. Oganov | ||
| "... The problem of vascular comorbidity in patients with cardiovascular diseases, its effect ..." | ||
| Vol 17, No 4 (2021) | Obstructive sleep apnea and cardiovascular comorbidity: common pathophysiological mechanisms to cardiovascular disease | Abstract similar documents |
| M. V. Agaltsov, O. M. Drapkina | ||
| "... Obstructive sleep apnea (OSA) is associated with many cardiovascular and metabolic diseases. Sleep ..." | ||
| Vol 6, No 4 (2010) | HYPOANDROGEN CONDITION AND CARDIOVASCULAR DISEASES: ACTUAL QUESTIONS OF COMORBIDITY IN CLINICAL PRACTICE | Abstract similar documents |
| G. G. Sharvadze, D. G. Kurbatov, E. A. Poddubskaya, M. N. Mamedov | ||
| "... The correlation of age-dependent reduction in sex hormones level and changes of cardiovascular ..." | ||
| Vol 5, No 4 (2009) | COMORBIDITY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: A ROLE OF CARDIOVASCULAR DISORDERS | Abstract PDF (Eng) similar documents |
| N. A. Karoli, A. P. Rebrov | ||
| "... Aim. To study prevalence and features of cardiovascular diseases (arterial hypertension, ischemic ..." | ||
| Vol 9, No 2 (2013) | CONTEMPORARY APPROACH TO THE CORRECTION OF COGNITIVE DISORDERS IN PATIENTS WITH VASCULAR COMORBIDITY | Abstract similar documents |
| S. A. Rumianceva, V. A. Stupin, V. V. Afanas'ev, E. V. Silina, S. P. Svishсheva, E. N. Kabaeva, L. A. Cukurova | ||
| "... Various aspects of the therapy of patients with cognitive impairments and vascular comorbidity ..." | ||
| Vol 17, No 4 (2021) | Inflammation and Comorbidity. Are There any Chances to Improve the Prognosis in Patients with Extremely High Cardiovascular Risk? | Abstract similar documents |
| M. V. Zykov, O. L. Barbarash | ||
| "... in a special category of patients with extremely high cardiovascular risk, as well as in patients with recent ..." | ||
| Vol 16, No 1 (2020) | Levocarnitine for the Treatment of Polymorbid Patients | Abstract similar documents |
| A. P. Pereverzev, D. A. Shevchenko, A. V. Filippova, A. A. Kirichenko, I. F. Krotkova, O. D. Ostroumova | ||
| "... . Of particular difficulty is the treatment of patients with cardiovascular comorbidity, which requires ..." | ||
| Vol 15, No 5 (2019) | Adverse Reactions of the Cardiovascular System when Taking Nonsteroidal Anti-inflammatory Drugs and Ways to Reduce Them | Abstract similar documents |
| N. V. Pyrikova, O. N. Antropova, I. V. Osipova | ||
| "... from the side of the cardiovascular system. The purpose of the review was to assess the adverse ..." | ||
| Vol 9, No 3 (2013) | PROBLEMS AND PROSPECTS OF INTERMEDIARY METABOLISM CORRECTION IN PATIENTS WITH VASCULAR COMORBIDITY | Abstract similar documents |
| S. A. Rumyantseva, R. G. Oganov, V. A. Stupin, E. V. Silina, A. S. Orlova, S. B. Bolevich, V. V. Afanasev, E. N. Kabaeva, S. A. Volik | ||
| "... a major role in heart and brain lesions of vascular origin. Features of the free-radical processes ..." | ||
| Vol 16, No 4 (2020) | Cardiovascular Comorbidity: Patient with Coronary Artery Disease and Peripheral Artery Atherosclerosis. How to Identify and Manage the Risks of Ischemic Events? | Abstract similar documents |
| O. L. Barbarash, V. V. Kashtalap, I. A. Shibanova | ||
| "... for practical health care. The positions of one of the components of cardiovascular comorbidity – multifocal ..." | ||
| Vol 17, No 6 (2021) | Prehospital Period in Patients with COVID-19: Cardiovascular Comorbidity and Pharmacotherapy During the First Epidemic Wave (Hospital Registry Data) | Abstract similar documents |
| S. Yu. Martsevich, M. M. Lukyanov, M. M. Pulin, N. P. Kutishenko, E. Yu. Andreenko, V. P. Voronina, V. A. Dindikova, N. A. Dmitrieva, A. V. Zagrebelnyy, O. V. Lerman, A. N. Makoveeva, E. Yu. Okshina, A. A. Smirnov, E. V. Kudryashov, I. V. Budaeva, E. S. Nikoshnova, O. E. Karpov, O. M. Drapkina | ||
| "... pneumonia (CAP), analyze the duration of the prehospital period, cardiovascular comorbidity and the quality ..." | ||
| Vol 13, No 5 (2017) | COMORBIDITIES IN PATIENTS WITH ISCHEMIC HEART DISEASE: GENDER DIFFERENCES | Abstract similar documents |
| A. N. Sumin, E. V. Korok, A. V. Shcheglova, O. L. Barbarash | ||
| "... Background. The problem of comorbidity in ischemic heart disease (IHD) has always been given ..." | ||
| Vol 16, No 6 (2020) | An Elderly Comorbid Patient with Atrial Fibrillation: What is Important to Know and What Should be Considered When Prescribing Anticoagulants? | Abstract similar documents |
| T. V. Pavlova | ||
| "... , the comorbidity increases the risk of bleeding. Older age is also the risk factor of thrombotic and hemorrhagic ..." | ||
| Vol 15, No 4 (2019) | Optimization of Pharmacotherapy with Direct Oral Anticoagulants: the Need to Choose the Right Dosage Regimen | Abstract similar documents |
| A. I. Kochetkov, O. D. Ostroumova | ||
| "... of their dosing, especially as a result of increasing in the number of patients with a complex cardiovascular risk ..." | ||
| Vol 20, No 6 (2024) | Medical treatment of cardiovascular diseases in patients after hospitalization for COVID-19 (three-year follow-up data in the TARGET-VIP registry) | Abstract similar documents |
| N. P. Kutishenko, S. Yu. Martsevich, M. M. Loukianov, E. Yu. Andreenko, V. P. Voronina, V. A. Dindikova, N. A. Dmitrieva, M. M. Kudryavtseva, O. V. Lerman, E. Yu. Okshina, A. A. Smirnov, A. G. Soplenkova, A. A. Pulin, N. N. Kuzina, D. A. Nefedova, V. G. Klyashtorniy, O. E. Karpov, O. M. Drapkina | ||
| "... Aim. To evaluate the quality of drug treatment of patients with cardiovascular diseases (CVD ..." | ||
| Vol 10, No 5 (2014) | OUTPATIENT REGISTRY OF CARDIOVASCULAR DISEASES (RECVASA): PROSPECTIVE FOLLOW-UP DATA, ESTIMATION OF RISKS AND OUTCOMES IN PATIENTS WITH ATRIAL FIBRILLATION | Abstract PDF (Eng) similar documents |
| M. M. Loukianov, S. A. Boytsov, S. S. Yakushin, S. Yu. Martsevich, A. N. Vorobyev, A. V. Zagrebelnyy, M. S. Kharlap, K. G. Pereverzeva, E. A. Pravkina, S. E. Serdyuk, A. D. Deev, E. N. Kudryashov | ||
| "... into the outpatient REgistry of CardioVAScular diseAses (RECVASA). 530 of 3690 (14.4%) patients had the diagnosis ..." | ||
| Vol 14, No 1 (2018) | COMORBID PATIENT IN GASTROENTEROLOGY: INDIVIDUAL APPROACH | Abstract similar documents |
| I. G. Bakulin, S. A. Sayganov, M. I. Skalinskaya, E. V. Skazyayeva, I. V. Lapinskii | ||
| "... of comorbid conditions have become of great interest among clinicians. Comorbidity, which increases ..." | ||
| Vol 15, No 5 (2019) | The Concept of Early Vascular Aging | Abstract similar documents |
| N. V. Burko, I. V. Avdeeva, V. E. Oleynikov, S. A. Boytsov | ||
| "... , vascular changes occur at a younger age, while the presence of only classical risk factors does not explain ..." | ||
| Vol 16, No 6 (2020) | Patients with Atrial Fibrillation in Clinical Practice: Comorbidity, Drug Treatment and Outcomes (Data from RECVASA Registries) | Abstract similar documents |
| M. M. Loukianov, E. Yu. Andreenko, S. Yu. Martsevich, S. S. Yakushin, A. N. Vorobyev, K. G. Pereverzeva, A. V. Zagrebelnyy, E. Yu. Okshina, V. V. Yakusevich, V. Vl. Yakusevich, E. M. Pozdnyakova, T. A. Gomova, E. E. Fedotova, M. N. Valiakhmetov, V. P. Mikhin, Yu. V. Maslennikova, V. G. Klyashtorny, E. V. Kudryashov, Ju. E. Tatsii, S. A. Boytsov, O. M. Drapkina | ||
| "... Aim. To study comorbidity, drug therapy and outcomes in patients with atrial fibrillation (AF ..." | ||
| Vol 16, No 3 (2020) | The Role of Magnesium in the Development of Cardiovascular Diseases and the Possibility of their Prevention and Correction with Magnesium Preparations (Part 2) | Abstract similar documents |
| A. S. Safaryan, V. S. Sargsyan, D. V. Nebieridze | ||
| "... Data on the effect of magnesium on the homeostasis of the body and on the cardiovascular system ..." | ||
| Vol 17, No 2 (2021) | Comorbidities and Percutaneous Coronary Intervention in Elderly Patients with Acute Coronary Syndrome | Abstract PDF (Eng) similar documents |
| M. Yu. Gilyarov, E. V. Konstantinova, M. R. Atabegashvili, T. D. Solntseva, D. A. Anichkov, А. N. Kostina, R. V. Polybin, A. E. Udovichenko, A. V. Svet | ||
| "... Aim. To assess comorbidities in elderly patients with acute coronary syndrome (ACS) and to analyze ..." | ||
| Vol 10, No 4 (2014) | DIAGNOSTICS, TREATMENT, ASSOCIATED CARDIOVASCULAR AND CONCOMITANT NON-CARDIAC DISEASES IN PATIENTS WITH DIAGNOSIS OF “ATRIAL FIBRILLATION” IN REAL OUTPATIENT PRACTICE (ACCORDING TO DATA OF REGISTRY OF CARDIOVASCULAR DISEASES, RECVASA) | Abstract PDF (Eng) similar documents |
| M. M. Loukianov, S. A. Boytsov, S. S. Yakushin, S. Yu. Martsevich, A. N. Vorobyev, A. V. Zagrebelnyy, M. S. Kharlap, K. G. Pereverzeva, E. A. Pravkina, S. E. Serdyuk, A. D. Deev, E. N. Kudryashov | ||
| "... Aim. To study the structure of risk factors and associated cardiovascular and concomitant non ..." | ||
| Vol 18, No 6 (2022) | Predictors of Long-Term Outcomes after Surgical Myocardial Revascularization | Abstract similar documents |
| V. S. Kaveshnikov, M. A. Kuzmichkina, V. N. Serebryakova | ||
| "... factors, in particular – age, set of cardiovascular risk factors (RF) and comorbidity, specifically ..." | ||
| Vol 17, No 4 (2021) | Assessment of Arterial Stiffness Using the Cardio-Ankle Vascular Index – What We Know and What We Strive for | Abstract similar documents |
| A. N. Sumin, A. V. Shcheglova | ||
| "... up new perspectives in the assessment of cardiovascular interactions, the study of vascular function ..." | ||
| Vol 17, No 5 (2021) | Combination of Atrial Fibrillation and Coronary Heart Disease in Patients in Clinical Practice: Comorbidities, Pharmacotherapy and Outcomes (Data from the REСVASA Registries) | Abstract PDF (Eng) similar documents |
| M. M. Loukianov, S. Yu. Martsevich, E. Yu. Andrenko, S. S. Yakushin, A. N. Vorobiev, K. G. Pereverzeva, A. V. Zagrebelny, Е. Yu. Okshina, V. V. Yakusevich, Vl. Vl. Yakusevich, E. M. Pozdnyakova, T. A. Gomova, E. E. Fedotova, M. M. Valiakhmetov, V. P. Mikhin, Yu. V. Maslennikova, E. N. Belova, V. G. Klyashtorny, E. V. Kudryashov, A. N. Makoveeva, Ju. E. Tatsii, S. A. Boytsov, O. M. Drapkina | ||
| "... Aim. Assess the structure of comorbid conditions, cardiovascular pharmacotherapy and outcomes ..." | ||
| Vol 17, No 4 (2021) | Epidemiological Observational Study on the Assessment of the Comorbidity and the Efficacy of the Treatment of Hypertensive Patients with Single Pill Combination of Lysinopril, Amlodipine and Rosuvastatin "PHENOTYPE-AG" | Abstract similar documents |
| M. P. Savenkov, S. N. Ivanov, M. V. Borschevskaya, I. N. Okuneva, S. V. Ivanova, A. M. Savenkova, R. V. Dushkin | ||
| "... Aim. To study the prevalence of comorbidity affecting the choice of antihypertensive treatment ..." | ||
| Vol 3, No 3 (2007) | REDUCTION OF CUMULATIVE CARDIOVASCULAR RISK IN PATIENTS WITH ARTERIAL HYPERTENSION: THE ROLE OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS ACCORDING TO THE NEW EUROPEAN RECOMMENDATIONS | Abstract similar documents |
| M. N. Mamedov, N. A. Chepurina, Z. N. Tokareva, A. A. Evdokimova | ||
| "... Conception of total cardio-vascular risk plays important role in defining tactics of arterial ..." | ||
| Vol 16, No 3 (2020) | Possibilities of Pulse Wave Contour Analysis in Diagnostics of Early Vascular Aging | Abstract similar documents |
| A. M. Tuktarov, A. E. Filippov, A. A. Obrezan, L. V. Kukol' | ||
| "... , arterial age and early vascular aging (EVA) in healthy individuals and patients with cardiovascular risk ..." | ||
| Vol 17, No 6 (2021) | Cardiovascular Diseases and Non-Alcoholic Fatty Liver Disease: Relationship and Pathogenetic Aspects of Pharmacotherapy | Abstract similar documents |
| A. V. Nelidova, M. A. Livzan, N. A. Nikolaev, T. S. Krolevets | ||
| "... The association of non-alcoholic fatty liver disease (NAFLD) and cardiovascular risk is currently ..." | ||
| Vol 4, No 2 (2008) | DIHYDROPYRIDINE CALCIUM ANTAGONISTS: THE ROLE IN CURRENT THERAPY OF CARDIO-VASCULAR DISEASES | Abstract similar documents |
| E. V. Shilova, S. Y. Martsevich | ||
| "... of cardiovascular complications are analyzed. The significant place of dihydropyridine CA in current guidelines ..." | ||
| Vol 18, No 1 (2022) | Cardiovascular Effects of Metformin | Abstract similar documents |
| B. T. Kurmanbekova, A. M. Noruizbaeva | ||
| "... , progression and mortality from cardiovascular diseases (CVD). The world communities are faced ..." | ||
| Vol 11, No 4 (2015) | SLEEP DURATION: MODERN VIEW OF THE PROBLEM FROM THE STANDPOINT OF A CARDIOLOGIST | Abstract similar documents |
| O. M. Drapkina, R. N. Shepel' | ||
| "... , including cardiovascular diseases is known and proven. In addition, the results of many clinical studies ..." | ||
| Vol 15, No 5 (2019) | The Role of Magnesium in the Development of Cardiovascular Diseases and the Possibility of their Prevention and Correction with Magnesium Preparations (Part 1) | Abstract similar documents |
| A. S. Safaryan, V. S. Sargsyan, T. V. Kamyshova, N. M. Akhmedzhanov, D. V. Nebieridze, E. A. Poddubskaya | ||
| "... and, in particular, on the cardiovascular system. It describes the importance of the presence and effects ..." | ||
| Vol 12, No 3 (2016) | EFFECT OF OBSTRUCTIVE SLEEP APNEA SYNDROME ON ARTERIAL STIFFNESS IN PATIENTS AT HIGH CARDIOVASCULAR RISK | Abstract PDF (Eng) similar documents |
| V. E. Oleynikov, N. V. Burko, L. I. Salyamova, K. A. Ziboreva | ||
| "... on endothelial function and vascular stiffness parameters in patients with arterial hypertension 1-2 degrees ..." | ||
| Vol 17, No 4 (2021) | E-cigarette Smoking (Vaping) and Markers of Vascular Wall Damage in Young Subjects without Cardiovascular Disease | Abstract PDF (Eng) similar documents |
| V. I. Podzolkov, A. E. Bragina, N. A. Druzhinina, L. N. Mohammadi | ||
| "... smoking on markers of vascular wall damage: high sensitivity C-reactive protein (hsCRP), albuminuria (AU ..." | ||
| Vol 9, No 4 (2013) | NORVASC® IN RUSSIA 20 YEARS LATER: CONTINUATION OF THE HISTORY | Abstract similar documents |
| A. V. Rudenko, B. A. Rudenko | ||
| "... cardiovascular events incidence in patients with atherosclerosis, even if they have no arterial hypertension ..." | ||
| Vol 13, No 5 (2017) | EFFECT OF LISINOPRIL ON 24-HOUR BLOOD PRESSURE AND ARTERIAL STIFFNESS IN PATIENTS WITH ARTERIAL HYPERTENSION AND RHEUMATOID ARTHRITIS | Abstract similar documents |
| O. L. Sarkisova, N. V. Rebrova, I. I. Bogomolova, E. A. Anisimova, R. S. Karpov, V. F. Mordovin, T. G. Khruleva | ||
| "... . A high incidence of traditional cardiovascular risk factors was identified: 95% of patients had ..." | ||
| Vol 20, No 5 (2024) | Lipoprotein(a), atherosclerosis and cardiovascular risk | Abstract similar documents |
| E. A. Polyakova, Iu. S. Khalimov, E. A. Bazhenova, T. M. Bakher | ||
| "... cardiovascular diseases. The atherogenicity of Lp(a) is 6 times higher than that of low-density lipoproteins ..." | ||
| Vol 1, No 2 (2005) | THE STATE OF ARTERIAL HYPERTENSION DIAGNOSTICS AND TREATMENT, ACCORDING TO THE RESULTS OF THE POLL AMONG PHYSICIANS OF VOLGOGRAD AND VOLGOGRAD REGION | Abstract similar documents |
| S. Y. Martsevich, N. S. Oganisyan, N. A. Dmitrieva, A. V. Klimakov | ||
| "... of cardiovascular complications. The same is observed for definition of AH grade according to the blood pressure ..." | ||
| Vol 15, No 3 (2019) | Atherosclerosis and Osteoporosis. Common Targets for the Effects of Cardiovascular and Anti-Osteoporotic Drugs (Part II). The Effect of Antiosteoporotic Drugs on the Vascular Wall State | Abstract similar documents |
| I. A. Skripnikova, O. V. Kosmatova, M. A. Kolchinа, M. A. Myagkova, N. A. Alikhanova | ||
| "... -osteoporosis therapy on the vascular wall and the development of calcification. The discovery of common ..." | ||
| Vol 15, No 6 (2019) | Association of Self-Perceived Health with Social and Psychological Environment, the Mode of Life and Cardiovascular Risk Markers in Middle-Aged Men – Residents of Moscow | Abstract PDF (Eng) similar documents |
| M. B. Kotova, V. B. Rozanov, E. I. Ivanova | ||
| "... environment, lifestyle and cardiovascular risk markers in middle-aged men. Material and methods. A total ..." | ||
| Vol 11, No 2 (2015) | CHRONIC KIDNEY DISEASE AND CARDIOVASCULAR DISEASES: FOCUS ON ATRIAL FIBRILLATION | Abstract similar documents |
| V. N. Shishkova | ||
| "... The question of mutual influence of risk factors for cardiovascular and renal diseases ..." | ||
| Vol 3, No 3 (2007) | STRESS: WHAT WE ACTUALLY KNOW ABOUT THIS RISK FACTOR? | Abstract similar documents |
| R. G. Oganov, G. V. Pogosova | ||
| "... Results of current studies devoted to relationship between stress and cardiovascular morbidity ..." | ||
| Vol 19, No 5 (2023) | Relationship between parameters of subclinical atherosclerosis and osteoporosis and their prognostic significance: data from the prospective studies | Abstract similar documents |
| I. A. Skripnikova, M. A. Kolchina, O. V. Kosmatova, T. T. Tsoriev, O. Yu. Isaykina, O. M. Drapkina | ||
| "... We analyzed modern publications on the relationship between cardiovascular diseases (CVDs ..." | ||
| Vol 13, No 1 (2017) | THE LINK BETWEEN VITAMIN В12 DEFICIENCY, RISK OF CARDIOVASCULAR DISEASES AND AGING PROCESS | Abstract similar documents |
| O. M. Drapkina, R. N. Shepel | ||
| "... of the cardiovascular system. Its connections to the increased incidence of myocardial infarction, stroke ..." | ||
| Vol 1, No 1 (2005) | ACE INHIBITORS IN PATIENTS WITH ISCHEMIC HEART DISEASE WITHOUT HEART FAILURE: CLASS EFFECTS AND EFFICACY OF ITS REPRESENTATIVES | Abstract similar documents |
| Y. A. Karpov | ||
| "... of coronary events development and cerebral-vascular complications is shown, as well as the overall mortality ..." | ||
| Vol 1, No 3 (2005) | COMPARATIVE ASSESSMENT OF EFFECT OF COMBINED DRUGS OF ACE INHIBITOR AND DIURETIC (“NOLIPREL FORTE” AND “CAPOZIDE”) ON CARDIOVASCULAR REMODELING IN HYPERTENSIVE PATIENTS | Abstract similar documents |
| T. D. Kaplanov, V. V. Ivanenko, N. V. Ryasancevа, A. V. Legkiy, L. P. Anisimova, Yu. M. Lopatin | ||
| "... Aim. To assess antihypertensive efficacy and effect on cardio-vascular remodeling of combined ..." | ||
| Vol 10, No 3 (2014) | OPTIMIZING THE TREATMENT OF PATIENTS WITH HYPERTENSION AND CORONARY HEART DISEASE WITH LERCANIDIPINE | Abstract similar documents |
| E. L. Trisvetova | ||
| "... Comorbidity of cardiovascular diseases reciprocally aggravates their course and induces the need ..." | ||
| Vol 3, No 3 (2007) | PHARMACOEPIDEMIOLOGICAL MONITORING OF ANTIDEPRESSANT USAGE IN PATIENTS WITH ANXIOUS AND DEPRESSIVE SYNDROMES IN INTERNAL MEDICINE | Abstract similar documents |
| N. V. Ivanova, B. B. Fischman, G. I. Schwartsman, L. A. Fomenko, A. A. Abdulin, M. S. Kazymov, I. V. Samsonova, M. A. Bobyr | ||
| Vol 18, No 1 (2022) | Preventive Screening of Young People from the Perspective of Vascular Aging Phenotypes: the Role of Body Weight | Abstract similar documents |
| M. Y. Evsevyeva, M. V. Eremin, M. V. Rostovtseva, O. V. Sergeeva, A. V. Rusidi, V. D. Kudryavtseva, E. V. Shchetinin | ||
| "... Aim. To study the cardiovascular stiffness index CAVI in relation to main risk factors (RF ..." | ||
| Vol 13, No 3 (2017) | ARTERIAL STIFFNESS AND CARDIOVASCULAR RISK FACTORS IN YOUNG MEN (41-44 YEARS) | Abstract PDF (Eng) similar documents |
| O. Yu. Isaykina, V. B. Rozanov, E. Yu. Zvolinskaya, H. S. Pugoeva, A. A. Alexandrov | ||
| "... Aim. To study the relationship of individual cardiovascular risk factors with arterial stiffness ..." | ||
| Vol 18, No 6 (2022) | What is changing in the treatment of acute coronary syndrome in the Russian Federation? | Abstract similar documents |
| S. A. Boytsov, B. G. Alekyan, R. M. Shakhnovich, V. I. Ganyukov | ||
| "... The work of the national network of vascular centers of the Russian Federation (RF), based ..." | ||
| Vol 12, No 5 (2016) | The Value of Subclinical Carotid Atherosclerosis for Primary Prevention of Cardiovascular Diseases. Review of the Main International Studies | Abstract similar documents |
| E. K. Butina, E. V. Bochkareva | ||
| "... Measures for the prevention of cardiovascular diseases (CVD) are more effective ..." | ||
| Vol 15, No 3 (2019) | Mammographic Screening as a Tool for Cardiovascular Risk Assessing. Part 2. Association of Breast Arterial Calcification and Cardiovascular Diseases | Abstract similar documents |
| E. V. Bochkareva, I. V. Kim, E. K. Butina, I. D. Stulin, S. A. Trukhanov, B. A. Rudenko, S. A. Boytsov, O. M. Drapkina | ||
| "... the stratification of cardiovascular risk in the female population are of increasing interest. The purpose of the 2 ..." | ||
| Vol 15, No 1 (2019) | Atherosclerosis and Osteoporosis. Common Targets for the Effects of Cardiovascular and Anti-osteoporotic Drugs (Part I). The Effect of Cardiovascular Drugs on Bone Strength | Abstract similar documents |
| I. A. Skripnikova, N. A. Alikhanova, M. A. Kolchinа, M. A. Myagkova, O. V. Kosmatova | ||
| "... of cardiovascular drugs, such as statins, beta-blockers, ACE inhibitors, diuretics, calcium antagonists and nitrates ..." | ||
| Vol 18, No 3 (2022) | The Effect of Enhanced External Counterpulsation on the Vascular State, Indicators of Glycemic Control and Quality of Life in Patients with Coronary Artery Disease and Type 2 Diabetes Mellitus | Abstract PDF (Eng) similar documents |
| O. A. Slepova, A. S. Lishuta, E. Yu. Vasiltsova, E. V. Privalova, Yu. N. Belenkov | ||
| "... , quality of life, structural and functional state of the vascular bed, and markers of glycemic control ..." | ||
| Vol 14, No 5 (2018) | Excessive Hypocoagulation in Therapy with Warfarin within Polypharmacy: Using online database Multi-Drug Interaction Checker and Graphic “Time-Effect-Drug Administration” to Eliminate Adverse Drug Event (Case Report) | Abstract similar documents |
| G. S. Krasnov, I. V. Kazancev | ||
| "... fibrillation and comorbidity. The patient had excessive polypharmacy level (11 drugs). Minor bleeding developed ..." | ||
| Vol 15, No 2 (2019) | Mammographic Screening as a Tool for Cardiovascular Risk Assessing. Part 1. Breast Arterial Calcification: Pathomorphology, Prevalence and Risk Factors | Abstract similar documents |
| E. V. Bochkareva, I. V. Kim, E. K. Butina, I. D. Stulin, S. A. Trukhanov, B. A. Rudenko, S. A. Boytsov, O. M. Drapkina | ||
| "... with cardiovascular diseases (CVD). This allows it to be considered as a new marker of cardiovascular risk in women ..." | ||
| Vol 13, No 4 (2017) | CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND ARTERIAL HYPERTENSION: VASCULAR WALL AS THE TARGET ORGAN IN COMORBID PATIENTS | Abstract similar documents |
| N. A. Karoli, A. P. Rebrov | ||
| "... and cardiovascular diseases. Aim. To reveal features of disturbances of arterial wall vasoregulatory function ..." | ||
| Vol 4, No 1 (2008) | MICROALBUMINURIA AS A FORECAST FACTOR FOR CARDIO-VASCULAR COMPLICATIONS AND A MARKER OF THERAPY EFFICACY IN PATIENTS WITH ARTERIAL HYPERTENSION | Abstract similar documents |
| L. A. Haisheva, L. I. Katelnitskaya | ||
| "... Aim. To assess the microalbuminuria (MAU) and vascular wall elasticity in patients with essential ..." | ||
| Vol 15, No 4 (2019) | Elderly Patients with Atrial Fibrillation: Focus on Comorbidity and Safety of Anticoagulant Therapy | Abstract similar documents |
| D. A. Napalkov, A. A. Sokolova | ||
| "... to the higher incidence of comorbidity. The presented material demonstrates the peculiarities of anticoagulant ..." | ||
| Vol 9, No 1 (2013) | OUTPATIENT REGISTER OF CARDIOVASCULAR DISEASES IN THE RYAZAN REGION (RECVASA): PRINCIPAL TASKS, EXPERIENCE OF DEVELOPMENT AND FIRST RESULTS | Abstract PDF (Eng) similar documents |
| S. A. Boytsov, S. S. Yakushin, S. Yu. Martsevich, M. M. Lukyanov, N. N. Nikulina, A. V. Zagrebelny, A. N. Vorobyov, K. G. Pereverseva, E. A. Pravkina, A. D. Deev, E. Yu. Andreenko, A. I. Ershova, A. N. Meshkov, R. P. Myasnikov, S. E. Serdyuk, М. S. Kharlap | ||
| "... Aim. To estimate risk factors and comorbidity structure, cardiovascular diseases outcomes ..." | ||
| Vol 9, No 2 (2013) | ROLE OF INSULIN RESISTANCE AND ITS CORRECTION IN THE PROCESS OF VASCULAR AGING | Abstract similar documents |
| E. N. Dudinskaya, O. N. Tkacheva, I. D. Strazhesko, D. U. Akasheva | ||
| "... . Data about the role of insulin resistance and its correction in vascular aging are presented. ..." | ||
| Vol 12, No 3 (2016) | NEW METHODS OF ASSESSMENT OF SUBCLINICAL CHANGES IN THE CARDIOVASCULAR SYSTEM IN ARTERIAL HYPERTENSION | Abstract PDF (Eng) similar documents |
| Zh. D. Kobalava, Yu. V. Kotovskaya, A. V. Bogomaz | ||
| "... The heart is related with vascular system anatomically and functionally. Structural and functional ..." | ||
| Vol 12, No 1 (2016) | Features of pharmacotherapy in the elderly patients. Introduction to the problem | Abstract similar documents |
| E. A. Ushkalova, O. N. Tkacheva, N. K. Runikhina, N. A. Chukhareva, A. Yu. Bevz | ||
| "... and pharmacodynamics, comorbidity, polypragmasy and treatment adherence among patients of this age group are presented. ..." | ||
| Vol 14, No 5 (2018) | Tactics of Antiarrhythmic Therapy in Comorbid Elderly and Senile Patients with Paroxysmal and Recurrent Atrial Fibrillation | Abstract similar documents |
| M. H. Fedorova, V. L. Doshchitsin, A. V. Chapurnykh | ||
| Vol 16, No 2 (2020) | Drug Correction of Vascular Remodeling in Patients with Hypertension: Results of 52-Week Prospective Study ARTERIA-AG | Abstract similar documents |
| O. V. Fedorishina, K. V. Protasov, A. M. Torunova | ||
| "... Aim. To study the long-term dynamics of vascular remodeling in patients with hypertension and high ..." | ||
| Vol 12, No 4 (2016) | Morphometric changes of the left ventricle and characteristics of peripheral hemodynamics in patients with drug resistant hypertension | Abstract similar documents |
| R. R. Kushkhova, A. G. Avtandilov | ||
| "... peripheral vascular resistance. Conclusion. Most of patients with drug resistant HT have concentric LV ..." | ||
| Vol 1, No 1 (2005) | MENOPAUSE AND CARDIOVASCULAR RISK | Abstract similar documents |
| D. A. Anichkov, N. A. Shostak, A. D. Zhuravleva | ||
| "... A role of menopause as a cardiovascular risk factor is reviewed. Menopause influence ..." | ||
| Vol 11, No 3 (2015) | PREVALENCE OF TYPE D PERSONALITY AND ITS ASSOCIATION WITH CARDIOVASCULAR DISEASES AND THEIR RISK FACTORS ACCORDING TO THE ESSE STUDY CONDUCTED IN KEMEROVO REGION | Abstract similar documents |
| A. N. Sumin, O. I. Raykh, E. V. Indukaeva, G. V. Artamonova | ||
| "... Aim. To study the prevalence of type D personality and its association with cardiovascular ..." | ||
| Vol 4, No 1 (2008) | ACHIEVEMENT OF LIPID TARGET PLASMA LEVELS IN PATIENTS OF HIGH CARDIOVASCULAR RISK: IS MEDICINE CHOICE IMPORTANT? | Abstract similar documents |
| S. Y. Martsevich, N. P. Kutishenko | ||
| Vol 11, No 6 (2015) | The influence of concomitant diseases on a long-term prognosis in patients with chronic ischemic heart disease according to the PROGNOZ IBS register | Abstract similar documents |
| S. N. Tolpygina, S. Yu. Martsevich, A. D. Deev | ||
| "... that were complications of IHD were considered as comorbidities as well as not cardiovascular diseases ..." | ||
| Vol 10, No 6 (2014) | THE SIGNIFICANCE OF PLATELET FUNCTIONAL ACTIVITY TESTING IN THE PREVENTION OF CARDIOVASCULAR COMPLICATIONS IN PATIENTS RECEIVING ANTIPLATELET THERAPY | Abstract similar documents |
| D. A. Andreev | ||
| "... Conclusion of Interdisciplinary Expert Council of Russian Association of Angiologists and Vascular ..." | ||
| Vol 16, No 4 (2020) | Inhibitors in the Management of Patients with Atherosclerotic Cardiovascular Diseases: Guidelines and Reimbursement Issues | Abstract similar documents |
| M. V. Zhuravleva, A. B. Prokofiev, E. V. Shikh, S. Yu. Serebrova, G. I. Gorodetskaya, E. Yu. Demchenkova | ||
| "... in a significant proportion of patients with atherosclerotic cardiovascular diseases (ACVD) is impossible ..." | ||
| Vol 9, No 1 (2013) | EFFECT OF DIFFERENT GLUCOSE BLOOD LEVELS ON THE DEVELOPMENT OF CARDIOVASCULAR DISEASES AND COMPLICATIONS | Abstract similar documents |
| E. V. Akhmedova, Z. A. Toguzova, M. N. Mamedov | ||
| "... growth rate of mortality. Glucose blood levels should be monitored to reduce the risk of cardiovascular ..." | ||
| Vol 4, No 1 (2008) | WHAT CAN WE EXPECT USING ACE INHIBITOR RAMIPRIL IN PERSONS WITH HIGH CARDIOVASCULAR RISK AND EARLY DISORDERS OF CARBOHYDRATE METABOLISM? LESSONS OF DREAM TRIAL | Abstract similar documents |
| M. N. Mamedov, M. B. Stroeva | ||
| "... Primary prevention of diabetes in persons with high cardiovascular risk is an actual problem ..." | ||
| Vol 1, No 3 (2005) | ASSESSMENT OF CUMULATIVE RISK OF CARDIO-VASCULAR DISEASES | Abstract similar documents |
| S. A. Shalnova, O. V. Vikhireve | ||
| "... Assessment of cumulative risk of cardio-vascular diseases. ..." | ||
| Vol 17, No 5 (2021) | Impact of Gut Microbiota on the Risk of Cardiometabolic Diseases Development | Abstract similar documents |
| L. E. Vasilyeva, O. M. Drapkina | ||
| "... comorbidities, such as hypertension, cardiac ischemia, heart failure and others. It is proved that gut ..." | ||
| Vol 14, No 2 (2018) | DOCTOR’S ADHERENCE TO RECOMMENDATIONS GOVERNING THE ANTIPLATELET AGENTS USE IN THE CARDIOVASCULAR DISEASES PREVENTION AND TREATMENT | Abstract similar documents |
| N. В. Perepech, A. V. Tregubov | ||
| "... for primary and secondary prevention of cardiovascular diseases. 276 questionnaires filled out by 185 ..." | ||
| Vol 17, No 2 (2021) | Features of Risk Stratification, Diagnosis and Secondary Prevention in Patients with Multifocal Arterial Disease. Part 2: Treatment Options | Abstract similar documents |
| V. G. Grachev, S. S. Vedenskaya, O. G. Smolenskaya | ||
| "... provides a more pronounced decrease in the incidence of cardiovascular complications than in lesions ..." | ||
| Vol 17, No 1 (2021) | Features of Risk Stratification, Diagnosis and Secondary Prevention in Patients with Multifocal Arterial Disease. Part 1: Risk Stratification and Diagnosis | Abstract similar documents |
| V. G. Grachev, S. S. Vedenskaya, O. G. Smolenskaya | ||
| "... Multifocal arterial disease is common in patients with atherosclerotic cardiovascular disease ..." | ||
| Vol 7, No 5 (2011) | DYNAMICS OF ACUTE CORONARY SYNDROME PATIENT MANAGEMENT IN NONIVASIVE PRIMARY VASCULAR CENTER (ACCORDING TO RECORD AND RECORD-2 REGISTERS) | Abstract similar documents |
| V. M. Provotorov, I. Shevchenko, R. Islamov | ||
| "... primary vascular center in 2007-2009. Material and methods. 188 (RECORD register data) and 180 (RECORD-2 ..." | ||
| Vol 16, No 4 (2020) | Changes in Arterial Wall Stiffness in Patients with Obesity and Paroxysmal Form of Atrial Fibrillation | Abstract PDF (Eng) similar documents |
| V. I. Podzolkov, A. I. Tarzimanova, A. E. Bragina, K. K. Osadchiy, R. G. Gataulin, K. A. Oganesyan, N. V. Lobova, Z. B. Jafarova | ||
| "... Aim. To study changes in vascular wall stiffness in patients with obesity and paroxysmal atrial ..." | ||
| Vol 2, No 4 (2006) | ANGIOTENSIN CONVERTING ENZYME INHIBITORS: DECREASE IN HEART REMODELING AND IMPROVEMENT IN FUNCTION OF ENDOTHELIUM IN PATIENTS WITH ARTERIAL HYPERTENSION | Abstract similar documents |
| K. Yu. Nikolaev, G. I. Lifshits, A. A. Nikolaeva, I. M. Gicheva | ||
| "... that 6 month enalapril treatment resulted in significant improvement of disturbed function of vascular ..." | ||
| Vol 20, No 3 (2024) | NLRP3 Inflammasome — a new universal target of asymptomatic hyperuricemia and gout management | Abstract similar documents |
| P. A. Lebedev, L. T. Volova, N. K. Osina, E. V. Paranina | ||
| "... in tissues and organs, leading to the formation of tophi, arthropathy, kidneys and cardiovascular system ..." | ||
| Vol 17, No 2 (2021) | The Role of Rivaroxaban in a Comprehensive Protection Strategy for Patients with Atrial Fibrillation | Abstract similar documents |
| I. A. Zolotovskaya, V. D. Sabanova, I. L. Davydkin | ||
| "... of this strategy is the control of comorbidities and risk factors for cardiovascular diseases. To date, rivaroxaban ..." | ||
| Vol 13, No 3 (2017) | SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES AMONG PATIENTS OF DIFFERENT AGE GROUPS WITH A HISTORY OF MYOCARDIAL INFARCTION BY THE EXAMPLE OF OUTPATIENT CARDIOLOGY INSTITUTION | Abstract similar documents |
| S. B. Fitilev, D. A. Dimitrova, I. I. Shkrebneva, A. V. Vozzhaev | ||
| "... Aim. To study secondary prevention of cardiovascular diseases among patients of different age ..." | ||
| Vol 16, No 3 (2020) | On the Quality of Medical Examination: Diagnostic Significance of the Survey Method for Detecting the Probability of Cardio-Cerebral Symptoms | Abstract similar documents |
| A. M. Kalinina, K. A. Antonov, B. E. Gornyi, I. I. Dubovoj, O. M. Drapkina | ||
| "... of medical examination and cardio vascular diseases prevention in outpatient medical care. ..." | ||
| Vol 21, No 2 (2025) | A randomized controlled trial of statin therapy effect on androgen status and erectile function in men with high and very high cardiovascular risk (TRISTAN): rationale and study protocol | Abstract similar documents |
| K. P. Raevskii, O. Yu. Nesterova, A. A. Strigunov, M. E. Chaliy, A. V. Kadrev, A. G. Plisyuk, A. A. Kamalov, Ya. A. Orlova | ||
| "... and erectile function in men aged 40-65 years with high and very high cardiovascular risk. Additionally ..." | ||
| Vol 5, No 4 (2009) | PRIMARY PREVENTION OF CARDIOVASCULAR COMPLICATIONS: VALUE OF STATINS | Abstract similar documents |
| S. Y. Martsevich, N. P. Kutishenko | ||
| "... The definition of primary prevention of cardiovascular diseases is presented. Statins preventive ..." | ||
| Vol 8, No 3 (2012) | MAGNESIUM-CONTAINING DRUGS IN CARDIOVASCULAR DISEASES | Abstract similar documents |
| A. V. Govorin, A. P. Filev | ||
| "... in different cardiovascular diseases are obtained. Physiological significance of magnesium is determined by its ..." | ||
| Vol 17, No 1 (2021) | Basic Aspects of Seasonal Cardiovascular Mortality | Abstract similar documents |
| G. F. Andreeva, V. M. Gorbunov | ||
| "... The review demonstrates the main aspects of seasonal cardiovascular mortality. Climatic factors ..." | ||
| Vol 5, No 3 (2009) | RISK FACTORS OF THE ERECTILE DYSFUNCTION IN THE PATIENTS WITH CARDIOVASCULAR DISEASES | Abstract similar documents |
| E. V. Minakov, R. A. Khokhlov, T. N. Kuznetsova, Y. V. Popovskaya, D. V. Snustikov, E. E. Tsareva, V. I. Yarliykova, N. M. Akhmedzhanov | ||
| "... to provide high level of compliance in patients with cardiovascular diseases. ..." | ||
| Vol 5, No 6 (2009) | EXPERIENCE OF RAMIPRIL (HARTIL) USAGE IN PATIENTS WITH HIGH CARDIOVASCULAR RISK (THE OPTIMIST STUDY) | Abstract similar documents |
| I. A. Velizhanina, L. I. Gapon, E. S. Velizhanina, M. I. Shupina, A. V. Rudakov, T. S. Bondarenko | ||
| "... with different cardiovascular risk (according to arterial hypertension (HT) risk stratification) in real clinical ..." | ||
| Vol 6, No 1 (2010) | THE BISOPROLOL — A HIGH SELECTIVE BETA-BLOCKER ACCORDING TO EVIDENCE BASED MEDICINE | Abstract similar documents |
| Yu. V. Lukina, S. Yu. Martsevich | ||
| "... Data of the evidence based medicine about bisoprolol treatment of patients with cardiovascular ..." | ||
| Vol 6, No 5 (2010) | LONG-TERM THERAPY WITH ACETYLSALICYLIC ACID. HOW TO AVOID THE POSSIBLE COMPLICATIONS? | Abstract similar documents |
| I. V. Zhirov | ||
| "... with cardiovascular diseases are presented. The main practical ways to reduce the possible gastrointestinal ..." | ||
| Vol 7, No 6 (2011) | DETERMINANTS OF PREVENTIVE BEHAVIOR REGARDING CARDIOVASCULAR DISEASES AND RISK FACTORS IN PATIENTS WITH ESSENTIAL HYPERTENSION AND CHRONIC ISCHEMIC HEART DISEASE | Abstract similar documents |
| D. Yu. Platonov, T. A. Kostjuk, A. I. Brandt, O. V. Tsygankova | ||
| "... logistic regression. Results. Awareness of the cardiovascular diseases (CVD) and its prevention (odds ratio ..." | ||
| Vol 9, No 3 (2013) | STATINS AND RISK OF INFECTIOUS DISEASES | Abstract similar documents |
| O. M. Drapkina, R. N. Shepel' | ||
| Vol 9, No 4 (2013) | STATINS IN PREVENTION OF ISCHEMIC STROKE | Abstract similar documents |
| A. V. Susekov, A. B. Blohin, Z. G. Luginova, E. J. Soloveva, N. V. Maltseva, O. E. Tarasova, V. V. Kuharchuk | ||
| Vol 10, No 5 (2014) | STATINS USE IN THE PERIOPERATIVE PERIOD ACCORDING TO THE EVIDENCE-BASED MEDICINE | Abstract similar documents |
| V. V. Samoylenko, O. P. Shevchenko, V. I. Burtsev | ||
| "... modification of cardiovascular complications in the perioperative period. Particular attention has recently ..." | ||
| 1 - 100 of 833 Items | 1 2 3 4 5 6 7 8 9 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
